🟢 Relay Therapeutics is trading 4.18% up in pre-market amid biotech-sector strength

Relay Therapeutics is trading at $19.18, up 4.18%, with biotech-sector strength the likeliest explanation; no direct cause is confirmed.

• Biotech was up 3.64% pre-market, but this sector context does not confirm a direct cause.
• No new company-specific announcement or catalyst surfaced for October 22; Relay Therapeutics’ investor-relations page lists prior second-quarter results, not a new release.
• Broader U.S. futures are lower, offering no same-direction support.